Joint Formulary & PAD

Sodium valproate (NON childbearing potential) - Epilepsy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Crushable tablets
  • Gastro-resistant tablets
  • Modified release tablets
  • Oral solution
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Capsules (slow release)
  • Granules (slow release)
Associated Icons :
SPC
Restrictions / Comments :
 

Status 3

Red
Formulations :
  • Injection
Associated Icons :
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Sodium valproate (NON childbearing potential)
Indication :
Epilepsy
Group Name :
Keywords :
valproic acid
Brand Names Include :
Epilim, Epilim Chrono, Chronosphere, Episenta, Epival CR, Dyzantil
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Traffic Light Entries :
3

Committee Recommendations (2)

Three infographics have been produced to clarify in which situations review by two specialists may be required for patients who are prescribed valproate:
•    for female patients under 55 years old
•    for male patients under 55 years old
•    for male and female patients 55 years and older

The Surrey Heartlands APC reviewed the Blue traffic light status for patients with epilepsy and WITHOUT child-bearing potential.

The Blue status remains with the expectation that treatment will be initiated and stabilised by a specialist and patients will receive a minimum of 1 month supply from the specialist before transfer of care.

No supplementary information sheet is required

Other Indications

Below are listed other indications that Sodium valproate (NON childbearing potential) is used to treat.

  • No records returned.